Home > > > Report Detail

YSELTY (LINZAGOLIX; OBE2109) - Emerging Drug Insight And Market Forecast - 2030

Publisher Name :
Date: 29-Oct-2020
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

"YSELTY (LINZAGOLIX; OBE2109) - Emerging Drug Insight and Market Forecast - 2030" the report provides comprehensive insights about an investigational product for Endometriosis in 7 Major Markets. A detailed picture of the YSELTY (LINZAGOLIX; OBE2109) in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2020-2030 is provided in this report along with a detailed description of the product. The product details cover mechanism of action, dosage and administration, route of synthesis, and Research and development activity including regulatory milestones, and other development activities. Further, it also consists of future market assessments inclusive of the market forecast, SWOT analysis, market competitors, and other emerging therapies.

Overview

Linzagolix is a novel, orally administered GnRH receptor antagonist with a potentially best-in-class profile in late-stage clinical development for the treatment of heavy menstrual bleeding associated with uterine fibroids and pain associated with endometriosis. Linzagolix acts by binding to and blocking the GnRH receptor in the pituitary gland, ultimately resulting in a dose-dependent reduction of the estrogen production by the ovaries. Through previously reported results from linzagolix and sophisticated pharmacological modelling, it has been established that maintaining estradiol within a specific target range provides the optimal balance between reducing symptoms while mitigating bone density loss associated with excessive estradiol suppression. ObsEva licensed linzagolix from Kissei in late 2015 and retains worldwide commercial rights, excluding Asia, for linzagolix.

Scope of the report

The report provides insights into:

- A comprehensive product

Overview including the product description, mechanism of action, dosage and administration, Research and Development activity.

- Elaborated details on regulatory milestones and other development activities have been provided in this report.

- The report also highlights the drug research and development activity details across the United States, Europe and Japan.

- The report also covers the patents information with expiry timeline around YSELTY (LINZAGOLIX; OBE2109).

- The report contains forecasted sales for YSELTY (LINZAGOLIX; OBE2109) till 2030.

- Comprehensive coverage of the late-stage emerging therapies (Phase II) for Endometriosis.

- The report also features the SWOT analysis with analyst insights and key findings of YSELTY (LINZAGOLIX; OBE2109).

Methodology

The report is built using data and information sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight's team of industry experts. Information and data from the secondary sources have been obtained from various printable and nonprintable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

YSELTY (LINZAGOLIX; OBE2109) Analytical Perspective by DelveInsight

- In-depth YSELTY (LINZAGOLIX; OBE2109) Market Assessment

This report provides a detailed market assessment of YSELTY (LINZAGOLIX; OBE2109) in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. This segment of the report provides forecasted sales data from 2020 to 2030.

- YSELTY (LINZAGOLIX; OBE2109) Clinical Assessment

The report provides the clinical trials information of YSELTY (LINZAGOLIX; OBE2109) covering trial interventions, trial conditions, trial status, start and completion dates.

Report highlights

- In the coming years, the market scenario for Endometriosis is set to change due to the extensive research and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market.

- The companies and academics are working to assess challenges and seek opportunities that could influence YSELTY (LINZAGOLIX; OBE2109) dominance. The therapies under development are focused on novel approaches to treat/improve the disease condition.

- Other emerging products for Endometriosis are giving market competition to YSELTY (LINZAGOLIX; OBE2109) and launch of late-stage emerging therapies in the near future will significantly impact the market.

- A detailed description of regulatory milestones, development activities, and some key findings provide the current development scenario of YSELTY (LINZAGOLIX; OBE2109).

- Our in-depth analysis of the forecasted sales data of YSELTY (LINZAGOLIX; OBE2109) from 2020 to 2030 will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the YSELTY (LINZAGOLIX; OBE2109).

Key Questions

- Which company is developing YSELTY (LINZAGOLIX; OBE2109) along with the phase of the clinical study?

- What is the technology utilized in the development of YSELTY (LINZAGOLIX; OBE2109)?

- What is the product type, route of administration and mechanism of action of YSELTY (LINZAGOLIX; OBE2109)?

- What is the clinical trial status of the study and study completion date?

- What are the key collaborations, mergers and acquisitions, licensing and other activities related to the YSELTY (LINZAGOLIX; OBE2109) development?

- What are the key designations that have been granted to YSELTY (LINZAGOLIX; OBE2109)?

- What is the forecasted market scenario of YSELTY (LINZAGOLIX; OBE2109)?

- What is the history of YSELTY (LINZAGOLIX; OBE2109) and what is its future?

- What is the forecasted sales of YSELTY (LINZAGOLIX; OBE2109) in the seven major countries, including the United States, Europe (Germany, France, Italy, Spain, and the United Kingdom), and Japan?

- What are the other emerging products available and how these are giving competition to YSELTY (LINZAGOLIX; OBE2109)?

- Which are the late-stage emerging therapies under development for the treatment of the PPD?

YSELTY (LINZAGOLIX; OBE2109) - Emerging Drug Insight And Market Forecast - 2030

Table of Contents

1. Drug Overview
1.1. Product Detail
1.2. Mechanism of Action
1.3. Dosage and Administration
1.4. Research and development activity
1.4.1. Clinical Development
1.4.2. Safety and Efficacy
1.5. Other Development Activities
2. Market Assesment
2.1. 7MM Market Analysis
2.2. The United States Market
2.3. Germany Market
2.4. France Market
2.5. Italy Market
2.6. Spain Market
2.7. United Kingdom Market
2.8. Japan Market
3. SWOT Analysis
4. Analyst Views
5. Market Competitors
6. Other Emerging Therapies
7. Appendix
8. Report Purchase Options

List of Tables

Table 1 YSELTY (LINZAGOLIX; OBE2109), Description
Table 2 YSELTY (LINZAGOLIX; OBE2109), Clinical Trial Description
Table 3 YSELTY (LINZAGOLIX; OBE2109), 7MM Market Size from 2020 to 2030 (in Million USD)
Table 4 Market Competitors
Table 5 Other Emerging Therapies

List of Figures

Figure 1 The Development Timeline of YSELTY (LINZAGOLIX; OBE2109)
Figure 2 Patent Details, YSELTY (LINZAGOLIX; OBE2109)
Figure 3 YSELTY (LINZAGOLIX; OBE2109), 7MM Market Size from 2020 to 2030 (in Million USD)
Figure 4 YSELTY (LINZAGOLIX; OBE2109), US Market Size from 2020 to 2030 (in Millions USD)
Figure 5 YSELTY (LINZAGOLIX; OBE2109), EU5 Market Size from 2020 to 2030 (in Millions USD)
Figure 6 YSELTY (LINZAGOLIX; OBE2109), Japan Market Size from 2020 to 2030 (in Millions USD)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs